Abstract

Compounds of the class of 4-oxo-butenoic acid derivatives are disclosure along with the surprising use property of these compounds as an anti-tumor agents in humans against breast carcinoma, which includes; 2-(N'-Fluoren-9-ylidene-hydrazino)-5,5-dimethyl-4-oxo-hex-enoic acid methyl ester (OF-06), 1-(2,4-Dimethyl-phenyl)-2,4-dihydroxy-3-(4-methyl-benzoyl)-5-oxo-2,5-dihydro-1H-pyrrole-2-carboxylic acid methyl ester (IF-07), 4-(4-Methoxy-phenyl)-2,4-dioxo-3-(phenyk-hydrazono)-butyric acid (3F-10, 4-(4-Chloro-phenyl)-2,4-dioco-3-(phenyl-hydrzono)-butyric acid ehtyl ester (3F-11), 2-Hyroxy-4-oxo-4-(2,3,5,6-tetrafluoro-4-methoxy-phenyl)-but-2-enoic acid (3F-15), and 4, 4-Dihyroxy-5-(4-methyl-benzoyl)-2-phenyl-2,4-dihdro-pyrazol-3-one (3F-16) as well as some novel derivatives of these compounds claimed. The invention also encompasses a class of the compounds with the novel property of anti-tumor activity agains human breast cancer, which includes the following compounds4-(4-Ethoxy-phenyl)-2-(N'-[1-(4-Chloro-phenyl)-ethylidene-hydrazino-2-hydroxy-4-oxo-butyric acid methyl ester (OF-13); 2-{N'-[1-(4-Chloro-phenyl)-ethylidene]-hydrazino]-4-oxo-4-phenyl-but-2-enoic-acid methyl ester (1F-04); amd 4-Chloro-4-(4-ethoxy-phenyl)-2-(fluoren-9-ylidene-hydrazono)-but-3-enoic acid methyl ester (3F-19).

Document Type

Patent

Patent Number

US 6,638,975

Application Serial Number

10/309,619

Issue Date

10-28-2003

Current Assignee

UCFRF

Assignee at Issuance

UCFRF

College

College of Sciences

Department

Chemistry

Allowance Date

3-13-2003

Filing Date

12-4-2002

Assignee at Filing

UCFRF

Filing Type

Nonprovisional Application Record

Donated

no

Download Patent

Share

COinS